PerkinElmer's Q1 Revenues Hit by Currency Translation, but Firm Beats Street EPS Estimate | GenomeWeb

NEW YORK (GenomeWeb) – PerkinElmer after the close of the market on Thursday reported a 1 percent dip year over year in its first quarter revenues, though on a constant-currency basis it had revenue growth of 5 percent.

For the three months ended March 29, 2015, PerkinElmer's revenues decreased to $526.9 million from $530.6 million in the prior-year period. Adjusted revenues for the quarter were $527.2 million compared to $532.1 million for Q1 2014, as the firm fell short of the average Wall Street estimate for revenues of $537.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.